Insight Strategy Advisors (ISA) is a healthcare consulting firm headquartered in New York City. ISA provides commercial development strategy expertise to multinational biopharmaceutical companies — serving clients in New York, Philadelphia, Chicago, Boston, Raleigh, San Francisco, Los Angeles, London, Paris, Tokyo and Switzerland.
ISA delivers value to clients through a diverse staff with expertise built from prior industry experience and direct industry knowledge gained from defining, creating, and executing commercial development strategies that maximize the economic value of therapeutic area franchises and products.
News Crawler
Advisory committee briefing documents state that the fixed-dose combination of immediate-release morphine and oxycodone was not superior to either of more >>
Sat, Apr 19, 2014 12:20:00 AM, Continue reading at the source
GlaxoSmithKline exec Klaus Edvardsen says the new label should give drug a boost, as previous indication was very restrictive. Approved more >>
Fri, Apr 18, 2014 10:50:00 PM, Continue reading at the source
Recent FDA guidance indicating that dietary supplement clinical studies with disease endpoints require an IND application could render the sale more >>
Fri, Apr 18, 2014 4:00:00 AM, Continue reading at the source